v3.26.1
Shareholders' Equity And Earnings Per Share - Schedule of Weighted Average Number of Shares (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Numerator:        
Net income attributable to Versigent $ 118 $ 107 $ 196 $ 202
Denominator:        
Weighted average ordinary shares outstanding, basic (in shares) 70,900 70,890 70,900 70,890
Dilutive shares related to restricted stock units (in shares) 980 0 490 0
Weighted average ordinary shares outstanding, including dilutive shares (in shares) 71,880 70,890 71,390 70,890
Earnings per share attributable to Versigent:        
Basic (in usd per share) $ 1.66 $ 1.51 $ 2.76 $ 2.85
Diluted (in usd per share) $ 1.64 $ 1.51 $ 2.75 $ 2.85